IDEXX beats Q1 earnings and revenue forecasts, raises 2021 guidance

IDEXX Laboratories Inc. (Nasdaq: IDXX) on Tuesday posted first-quarter results that surpassed market forecasts and raised its 2021 outlook to reflect expectations for higher organic revenue growth and better operating margins.

The Westbrook-based provider of veterinary diagnostics, veterinary practice software and water microbiology testing said that first-quarter revenue was $778 million, an increase of 24% on a reported basis and 21% higher organically over a year earlier. That exceeded the consensus forecast of analysts polled by Zacks Investment Research by 5.87%. Read more

Related Posts

Maine’s life sciences sector growth could outpace other industries

Maine’s $2.3 billion life sciences sector, which employed close to 10,000 people in 2024, will outpace the growth of many other...

13 January 2025

IDEXX gets wiggle room to buy back more shares

IDEXX Laboratories Inc. (Nasdaq: IDXX), a Westbrook-based maker of veterinary diagnostics and software, has the green light from its board of...

10 December 2024

Maine’s first accredited lab for PFAS testing is expanding to meet demand

NORRIDGEWOCK, Maine — This week, the Biden administration moved to prevent dangerous “forever chemicals” from being released onto the market after a less...

6 December 2024